Axis Spine Technologies

About Axis Spine Technologies

Axis Spine Technologies is a medical device company, with operations in the UK and US, that develops spinal implants for anterior lumbar surgery. Founded in 2017 by Jon Arcos, the company focuses on creating modular spinal cages that allow surgeons to build patient-specific implants intra-operatively. Arcos, who has nearly three decades of experience in the spinal implant industry with companies like Johnson & Johnson and NuVasive, established Axis to address clinical challenges in spinal alignment and cage subsidence.

The company's core technology is a platform of modular implants designed to reduce the risk of post-operative spinal segment collapse and improve alignment for patients with chronic back pain and spinal deformity. These modular cages are inserted with less force than conventional implants, minimizing the risk of damage to vertebral endplates. The firm's flagship product, the Axis-ALIF, received FDA 510(k) clearance in May 2020, and the first surgery using the device was completed in November 2020. The system offers surgeons extensive correction capabilities, including sagittal and coronal adjustments, using a limited inventory of modular components. The company is also developing implants for other surgical approaches, including Oblique Lateral Interbody Fusion (OLIF) and Lateral Lumbar Interbody Fusion (LLIF), as well as an advanced retractor system.

Axis Spine Technologies operates on a B2B business model, selling its implant systems to hospitals and spine centers. Its primary market is the United States, where it has clinically introduced its devices in select centers. The company has secured significant funding to support its commercial expansion and product development. Notable funding rounds include a £2.2 million round in January 2021 and a $12.5 million Series A round in October 2022, led by investors such as Mercia Asset Management, ACF Investors, and MedTex Ventures.